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Zika virus (ZIKV) is a mosquito-borne Flavivirus discovered in Uganda in the 1940s.
To date, three major ZIKV outbreaks have been reported. ZIKV infections have known
to be primarily asymptomatic while causing mild illness in a few cases. However, the
recent emergence and spread of ZIKV in the Americas has resulted in the declaration
of “Public Health Emergency of International Concern” due to the potential association
between the infection and prenatal microcephaly or other brain anomalies. In Brazil,
a 20-fold increase in prenatal microcephaly cases and 19% increase in Guillain-Barré
Syndrome (GBS) cases were reported in 2015, as compared to the preceding year.
The probable deleterious effects of ZIKV infection prompt the urgent development
of diagnostics and therapeutics. To this end, the existing evidences supporting the
increasingly common prenatal microcephaly and GBS association and the current known
ZIKV transmission dynamics, modes of detection (molecular and serology-based), and
current control strategies are summarized in this review. This review also emphasizes the
importance of understanding ZIKV transmission in order to design a sensitive yet cost
and time-efficient detection technique. Development of an efficient detection technique
would subsequently allow for better surveillance and control of ZIKV infection. Currently,
limited literature is available on the pathogenesis of ZIKV, hence, focusing on the modes
of ZIKV transmission could potentially contribute to the understanding of the disease
spectrum and formulation of targeted treatment and control.
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INTRODUCTION TO ZIKA VIRUS
Zika virus (ZIKV), a mosquito-borne Flavivirus belonging to the Flaviviridae family, is an emerging
pathogen that is spreading rapidly across the Americas, raising concerns in the forefront of global
healthcare (Ayres, 2016). The virus is closely related to other members of the Flavivirus genus
(positive-sense, single-stranded RNA viruses), including the dengue virus (DENV),West Nile virus
(WNV), yellow fever virus (YFV), tick-borne encephalitis virus (TBEV), and Japanese encephalitis
virus (JEV) (Lazear and Diamond, 2016). Although, ZIKV infection is reported to be subclinical
in approximately 80% of the cases, the virus has recently raised a “Public Health Emergency of
International Concern” due to the dramatic increase in the cases of prenatal microcephaly and
Guillain-Barré Syndrome (GBS) in ZIKV endemic regions (Basarab et al., 2016). Microcephaly is
characterized by at least two standard deviation reduction in brain volume intellectual and motor
disabilities, and behavioral issues (Petersen L. R. et al., 2016). Multiple development factors, such
as genetic, environmental, and infectious exposure, during pregnancy are known to contribute to
the onset of prenatal microcephaly. Therefore, further efforts are required toward eliminating any
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potentially associated confounding factor (Weaver et al., 2016).
GBS, on the other hand, is a rare autoimmune disorder of
the peripheral nervous system which could result in muscle
weakness, paralysis, or even death (Lazear and Diamond, 2016).
The plausible association between ZIKV infection and prenatal
microcephaly/GBS is yet a matter of debate among researchers.
It was suggested that the rise in the number of prenatal
microcephaly and GBS cases could potentially be attributed by
increased awareness and/or misdiagnosis (Mlakar et al., 2016).
To date, the exact ZIKV transmission dynamics have not been
established. ZIKV has been isolated from humans, non-human
primates, and multiple species of mosquitoes, suggesting a
complex transmission network (Lazear and Diamond, 2016).
Investigation of other potential inter-human modes of ZIKV
transmission, such as sexual, blood-related, or maternal
transmission, has allowed refinement of precautionary measures
for ZIKV prevention and novel modes of ZIKV detection.
Greater understanding of ZIKV transmission dynamics could
also further aid in the development of a precise, rapid and simple
tests for ZIKV detection in humans and mosquitoes. The robust
detection method could in-turn improve the control of ZIKV,
further preventing it from spreading around the globe (Pardee
et al., 2016). With the severity of ZIKV associated diseases and
the urgent need to develop methods to control its spread, in
this review we aim to provide consolidated up-to-date available
information on ZIKV associated prenatal microcephaly and
GBS, ZIKV transmission dynamics, current molecular and
serology-based modes of ZIKV detection, and the latest ZIKV
control strategies in place.
Epidemiology
ZIKV was first isolated from the blood of a febrile sentinel rhesus
monkey in the Zika Forest of Uganda in 1947 (Dick et al., 1952;
Lanciotti et al., 2008; Haddow et al., 2012). In the following years,
ZIKV was isolated from various species of Aedes mosquitoes
(Mlakar et al., 2016; Slavov et al., 2016). The first case of ZIKV
infection in humanwas reported in Nigeria in 1954 (MacNamara,
1954). Since then, a number of significant outbreaks have been
reported, prominently in the African and Southeast Asian region
(Pan American Health Organization, 2016c).
The first major ZIKV outbreak occurred in 2007 on the
Yap Island, Federated States of Micronesia, with approximately
75% of the population being affected within a period of 4
months (Saiz et al., 2016). Subsequently, in 2013 and 2014,
ZIKV epidemic was reported in the French Polynesia, Cook
Islands, Ester Islands, and New Caledonia. In 2015, ZIKV
outbreak was reported in Brazil and henceforth has spread across
Abbreviations: CHIKV, Chikungunya virus; DC-SIGN, Dendritic Cell-Specific
Intercellular adhesion molecule-3-Grabbing Non-integrin; DENV, Dengue virus;
ELISA, Enzyme-Linked Immunosorbent Assay; ER, Endoplasmic reticulum; GBS,
Guillain-Barré Syndrome; HPV, Human papillomavirus; HSV, Herpes simplex
virus; Ig, Immunoglobulin; JEV, Japanese encephalitis virus; NASBA, Nucleic acid
sequence-based amplification; NS5, Non-structural viral protein 5; PM, Prenatal
microcephaly; PRNT, Plaque reduction neutralization test; qRT-PCR, Real time
quantitative RT-PCR; RT-PCR, Reverse transcription polymerase chain reaction;
RT-PCR, Reverse transcription polymerase chain reaction; TBEV, Tick-borne
encephalitis virus; UTR, Untranslated region; WHO, World Health Organization;
WNV, West Nile virus; YFV, Yellow Fever virus; ZIKV, Zika virus.
the Latin America, Caribbean, and other parts of the world
causing a pandemic (Lazear and Diamond, 2016). As of March
2016, ZIKV had spread to 33 countries in the Americas, with
approximately over 1.5 million cases reported (Ayres, 2016;
Petersen L. R. et al., 2016). By July 7th 2016, autochthonous
cases of ZIKV had been reported in 40 countries within the
Americas (Pan American Health Organization, 2016b). The exact
global prevalence of ZIKV infection has not been reported
due to the absence of a standardized protocol for differential
diagnosis and clinical resemblance to other Flavivirus infections.
In addition, ZIKV is known to be self-limiting (asymptomatic
in approximately 80% of the cases), hence, it is likely that the
infection is underdiagnosed/underreported in a disease-endemic
setting (Gourinat et al., 2015).
It is anticipated that ZIKV would further spread around the
globe, particularly via viremic travelers or the movement of
infected mosquitoes (Petersen L. R. et al., 2016). More recently,
autochthonous ZIKV transmission as well as cases of ZIKV
transmission via sexual activity were reported in the United States
(Centers for Disease Control and Prevention, 2016b; Hills et al.,
2016). Currently, autochthonous vectorial ZIKV transmission
has not been reported in Europe, although imported and locally
sexually transmitted cases have been reported (Tappe et al., 2014;
Saiz et al., 2016; Venturi et al., 2016).
Continuous global surveillance is advised as situations may
change following the start of warmer weathers, allowing ZIKV
mosquito vectors to become active (Imperato, 2016; Saiz et al.,
2016).
Molecular Classification
Although, limited molecular data of the ZIKV genome sequence
from human isolates are currently available, sufficient data
exists to determine the evolutionary patterns of the virus
(Petersen L. R. et al., 2016). Through ZIKV genome sequencing
and phylogenetic analysis of several human isolates, three
geographically distinct lineages of ZIKV have been reported,
including the East African, West African, and the Asian strains
(see Figure 1). It is postulated that ZIKV originated in the
Eastern region of Africa and then spread toward the West
(Lanciotti et al., 2016). In the late 1960s, the first Asian ZIKV
was isolated in Malaysia and then subsequently, the virus
spread across southeast Asia (Marchette et al., 1969). It is
postulated that the Asian ZIKV strain emerged as a result
of accumulation of mutations in the ZIKV genome, hence,
introducing newmolecular interacting partners with the host cell
factors and changes in disease pathogenicity, vector competence,
and epidemic potential (Lazear and Diamond, 2016; Wang et al.,
2016; Weaver et al., 2016). At this point, it must be noted that
when compared to other RNA viruses, fixation of a mutation in
the genome of an arbovirus faces greater constraints due to the
presence of important genes required for replication in mammals
and invertebrates (Holmes, 2003; Hamel et al., 2015).
The current ZIKV outbreaks in the Americas, and previously
in the French Polynesia and Yap Islands, are reported to be
most closely related to the Asian strain (see Figure 1; Haddow
et al., 2012; Imperato, 2016). Through genome analysis and
phylogenetic studies, it was found that the ZIKV currently
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FIGURE 1 | ZIKV phylogenetic tree showing the three ZIKV lineages
constructed using the complete NS5 nucleotide sequence. The scale
bar indicates 0.03 substitutions/site. Modified from: Saiz et al. (2016).
circulating in the Americas share >99% identity with ZIKV
isolates from the French Polynesia outbreak and is 89%
identical to the African strain (Lanciotti et al., 2016; Lazear
and Diamond, 2016). The high genomic similarity of the ZIKV
strains circulating in the Americas allow for targeted drug and
therapeutic development (Petersen L. R. et al., 2016). Recent
studies focusing on the phylogenetic relationship between ZIKV
and other Flaviviruses have also contributed to the understanding
of the nature of ZIKV. Upon constructing phylogenetic trees
based on the non-structural viral protein 5 (NS5) and the
structural viral protein E, it was found that although the ZIKV
has the potential to affect the central nervous system, particularly
in neonates, it however is not particularly related to other
encephalitic viruses (Wong et al., 2016).
Virology and Pathogenesis
ZIKV, a biosafety level-2 pathogen, has an enveloped positive-
sense, single-stranded RNA genome with a size of approximately
10,676 bp and is known to be closely related to the Spondweni
virus (Charrel et al., 2016; Wong et al., 2016). ZIKV virions
are approximately 60 nm in size and spherical in shape (Charrel
et al., 2016). The ZIKV genome encodes for a single polyprotein
(approximately 3400 amino acids) that is subsequently processed
by host and viral proteases into ten different proteins, consisting
of three structural and seven nonstructural proteins (see
Figure 2; Saiz et al., 2016). Table 1 summarizes the function of
each ZIKV protein based on the general information collectively
available for Flaviviruses (Wong et al., 2016).
Currently, little information is available regarding ZIKV
pathogenesis, as compared to other members of the Flavivirus
genus. Generally, arboviruses (mosquito-borne viruses)
are known to replicate in dendritic cells and subsequently
disseminate to the lymph nodes and bloodstream (Diamond
et al., 2004). Within the cells, replication of Flaviviruses is known
to occur in the cytoplasmic region however, ZIKV antigens
have been observed within the cell nuclei. Hence, it is suggested
that ZIKV replication may differ from that of other Flaviviruses
(Buckley and Gould, 1988). In addition, according to a study
by Priyamvada et al. (2016), the potential association between
ZIKV and prenatal microcephaly/GBS may be attributed by
the introduction of ZIKV into a population with high flaviviral
background (e.g., prior exposure to DENV). The immunity
established against other Flaviviruses may play a role in the
modulation of ZIKV pathogenesis (Fajardo et al., 2016).
To study ZIKV pathogenesis, efforts have been put toward the
investigation of murine models with different manifestations of
ZIKV infection (Shah and Kumar, 2016). A study by Dick (1952)
showed motor weakness and paralysis in mice intracerebrally
infected with ZIKV strain M766 isolated from the brain of
young infected mice. Previous studies have also suggested that
glycosylation of viral E protein is associated with the ability of
Flaviviruses to cause a pandemic (Shirato et al., 2004). Recently, E
protein analysis of multiple pathogenic ZIKV strains circulating
in the Americas indicated positive glycosylation patterns. In
contrast, majority of the other ZIKV strains were found to
lack E protein glycosylation (Baronti et al., 2014; Berthet et al.,
2014). These findings suggest that E protein glycosylation may be
indicative of ZIKV pathogenicity (Saiz et al., 2016).
Host Cell-virus Interaction
According to a study by Hamel et al. (2015), ZIKV host cell
entry and endocytosis occurs via interactions of viral E proteins
with host cell adhesion factors, such as DC-SIGN (Dendritic
Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-
integrin) and multiple members of the phosphatidylserine
receptor family. The acidic environment within the endosome
promotes viral envelope and endosome membrane fusion (low
pH promotes E glycoprotein rearrangement) hence, allowing
the release of ZIKV RNA genome into the cytoplasm for
the initiation of translation (Saiz et al., 2016). Subsequently,
translated viral proteins aid in viral genome replication at the
surface of the endoplasmic reticulum (ER) (Hamel et al., 2015).
Within the ER, positive strand viral RNA is packaged to form
immature virions. The virus matures in the trans-Golgi network,
upon the cleavage of prM into M protein. ZIKV is then released
into the surroundings via exocytosis (Roby et al., 2015). Scarce
information is available regarding host cell response to viral
genome replication. According to Hamel et al. (2015), ZIKV
replication induces innate viral response and transcription of
interferon stimulated genes.
Symptoms
Up to 80% of human ZIKV infections appear to be asymptomatic,
with a small subset of cases presenting with mild clinical
symptoms similar to other flaviviral and influenza infections
(Marano et al., 2016; Shah and Kumar, 2016). Clinical
manifestation in symptomatic cases tend to appear after an
incubation period of 3 to 12 days and are reported to be
characterized by fever, rashes, myalgia, arthralgia, conjunctivitis,
gastrointestinal disturbance, and headaches (Buathong et al.,
2015; Basarab et al., 2016). However, major concern is associated
with the steep increase in reported cases of prenatal microcephaly
and GBS in the Americas after the recent ZIKV outbreak (Mlakar
et al., 2016). To this regard, it must be pointed out that prenatal
microcephaly and GBS have been implicated in other flaviviral
infections, such as by DENV and WNV (Weaver et al., 2016).
Teratogenic effects of flaviviral infections have been reported to
target the eyes and brain. Recent studies have suggested ZIKV
infections to be highly neurotrophic, with a few cases reporting
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FIGURE 2 | Genomic structure of ZIKV flanked by the 3′ and 5′ untranslated region (UTR). Redrawn from: Marano et al. (2016).
association with bilateral macular and perimacular lesions
(Mlakar et al., 2016; Ventura et al., 2016). Such complications
following ZIKV infection were undocumented in the 1950s.
Hence, it is evident that ZIKV genetic evolution (emergence
of Asian lineage) has resulted in increased virus pathogenicity
(Oehler et al., 2014; Rasmussen et al., 2016).
In 2015, amid the ZIKV epidemic, an astounding 20-fold
increase in prenatal microcephaly cases were reported in Brazil,
as compared to 2014 (Fauci and Morens, 2016). Since October
2015 up until now, approximately 4000 ZIKV infection-related
prenatal microcephaly cases have been reported in Brazil, causing
over 40 infant deaths (Higgs, 2016). During the outbreak, Paraíba
(north-east Brazil), a ZIKV endemic state, was reported to have
significantly increased cases of prenatal microcephaly, from 5.7
per 100,000 live births in 2010 to 99.7 per 100,000 live births
(Basarab et al., 2016). In addition, 1708 cases of GBS were
reported in 2015 in Brazil, a 19% increase as compared to
the preceding year (Basarab et al., 2016). Besides that, a case-
control study based on the French Polynesia ZIKV outbreak
indicated that patients with GBS were more likely to have a
history of ZIKV as compared to the control group (Cao-Lormeau
et al., 2016). Another study reported 20-fold increase in GBS
cases following the French Polynesia outbreak (Oehler et al.,
2014).
A recent study on mouse models reported teratogenic effects,
such as neuronal cell death and microcephaly, in pups born to
SJL mice infected with ZIKV during pregnancy (Cugola et al.,
2016). The precise mechanism by which ZIKV causes prenatal
microcephaly or GBS is yet unknown. Increased incidences of
microcephaly and GBS in regions positive for ZIKV circulation
and evidence from clinical and epidemiological studies have
increasingly been pointing toward a plausible causal association
(Rasmussen et al., 2016). Table 2 summarizes the studies
supporting the plausible association between ZIKV infection and
prenatal microcephaly and GBS.
Life Cycle
To date, ZIKV has been isolated from a vast range of organisms,
including humans, non-human primates (apes, monkeys, and
orangutans), and mosquitoes. Antibodies against ZIKV have
also been detected in vertebrates (rodents, birds, sheep, goats,
cattle, reptiles), hence, suggesting their potential role in the
circulation of ZIKV (Johnson et al., 1977). The African ZIKV
lineage is thought to be maintained via the sylvatic/enzootic
transmission cycle primarily between non-human primates (apes
and monkeys) and mosquitoes, with humans as incidental hosts.
However, humans have most likely become the prominent host
for the Asian ZIKV lineage (Althouse et al., 2016; Basarab
et al., 2016). Through evolution, ZIKV has gained the ability
to sustain transmission in a human-endemic cycle (suburban-
urban transmission cycle) thus, allowing humans to serve as
the carrier, multiplier, and source of ZIKV for uninfected
mosquitoes (see Figure 3; Saiz et al., 2016). The suburban-urban
transmission cycle is thought to cause and sustain epidemics
(Lazear and Diamond, 2016). Current research on ZIKV life
cycle focuses on determining the possibility and impact of ZIKV
sylvatic cycle establishment within the Americas. Such studies
have highlighted the importance of targeted surveillance of the
susceptible animal population for enzootic ZIKV (Fauci and
Morens, 2016).
ZIKV TRANSMISSION DYNAMICS
Mosquito-Borne Transmission
ZIKV transmission to humans occur primarily through
bites of an infected, day-dwelling female Aedes aegypti
or Aedes albopictus mosquito, similar to the transmission
of chikungunya virus (CHIKV) and DENV. A. aegypti
mosquitoes are confined to the tropical and sub-tropical
regions, hence, limiting ZIKV transmission potential (Petersen
L. R. et al., 2016). However, A. albopictus mosquitoes are
known to be geographically distributed throughout the tropical,
subtropical, and temperate regions, hence, allowing for greater
transmission potential (Thomas et al., 2012). The exact
incubation period for ZIKV before the mosquito becomes
capable of transmitting the virus is yet unknown. However,
according to Hayes (2009), the extrinsic incubation period
of ZIKV in mosquitoes is suggested to be approximately 10
days. Currently, it is presumed that uninfected mosquitoes are
capable of acquiring ZIKV by feeding on an infected human
(approximately during the time of clinical manifestation in
humans). To this regard, further studies must be conducted
to confirm that the viral titer level in the serum of infected
individuals is sufficient to infect a naïve mosquito (Grard et al.,
2014).
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TABLE 1 | Function and cellular localization of ZIKV proteins (Kostyuchenko et al., 2016; Lazear and Diamond, 2016; Wong et al., 2016).
Viral proteins Protein localization Function
E Structural surface protein Host receptor binding, host cell fusion, and viral entry
prM, M Structural surface protein E protein stabilization and host cell fusion
C Structural core protein Binds to viral RNA for nucleocapsid formation
NS1 Viral replication
NS2a Viral transcription and assembly
NS2b NS3 cofactor for appropriate serine protease function
NS3 Not a part of the virus particle. Encoded by the viral RNA genome and translated
using host cellular machinery
Serine protease, RNA helicase, and triphosphatase activity
NS4a Viral replication
NS4b Viral replication
NS5 Viral replication, RNA-dependent RNA polymerase, RNA
capping, methyltransferase activity
To date, ZIKV has been isolated from 17 different Aedes
mosquito species as well as Culex perfuscus,Mansonia uniformis,
Anopheles coustani, and Anopheles gambiae mosquitoes
(Ayres, 2016; Saiz et al., 2016; Slavov et al., 2016). It is
postulated that the enzootic maintenance of ZIKV occurs
through these mosquito species however, ZIKV transmission
to humans is contributed only by a subset of these species
(Lazear and Diamond, 2016). To date, vector competence
and maintenance of the suburban-urban ZIKV transmission
has been reported in A. aegypti, A. albopictus, A. hensilli
(responsible for Yap Island outbreak), and A. polynesiensis
(responsible for French Polynesia outbreak) (Imperato,
2016; Lazear and Diamond, 2016). The principle vector
currently responsible for spreading ZIKV within the Americas
include the A. aegypti and A. albopictus species (Petersen
L. R. et al., 2016). The involvement of a diverse range of
mosquito species in the maintenance of ZIKV suggests that the
transmission dynamics of ZIKV is complex (Althouse et al.,
2016).
Sexual Transmission
Multiple cases of male-to-female ZIKV transmission have been
reported thus, raising the concern of a novel mode of ZIKV
transmission in the human semen (Imperato, 2016). In 2011, a
case study reported ZIKV transmission from an infected male
to his female partner via sexual intercourse after the patient
returned from Senegal to the United States (Foy et al., 2011).
Serologic testing detected ZIKV RNA in both male and female
partners. A similar study indicated the development of ZIKV
infection in a female (confirmed via RT-PCR on serum sample)
13–14 days after having sexual intercourse with an infected male
who had recently returned from the Caribbean (Hills et al., 2016).
Three other similar cases have also reported coherent findings
(Foy et al., 2011; Hills et al., 2016). In all the cases reported, the
female partners had not traveled out of the United States and
local mosquito-borne transmission was not considered due to
vector absence within the geographical location. Until recently,
ZIKV has been thought to be transmitted only frommales to their
sexual partner. On 15 July 2016, the first female-to-male sexual
transmission of ZIKV was reported, further raising concerns that
ZIKV could spread more widely (Centers for Disease Control
and Prevention Newsroom, 2016; Davidson et al., 2016; Santora,
2016).
Recently, a study reported detection of ZIKV RNA via qRT-
PCR in the semen of infected males up to 188 days after the onset
of symptoms, even after viremia had cleared (serum negative
for ZIKV RNA) (Nicastri et al., 2016). The detection of high
infectious viral load and ZIKV RNA in semen suggest prolonged
potential for sexual transmission (Atkinson et al., 2016; Mansuy
et al., 2016; Nicastri et al., 2016). However, the mechanism
underlying the sexual transmission of ZIKV from a male to the
female partner is yet unknown. ZIKV is by far the first arbovirus
to be detected in human semen (Musso et al., 2015b).
Recent studies have reported the detection of ZIKV RNA and
infectious viral load in the saliva and urine of infected individuals
(Gourinat et al., 2015; Barzon et al., 2016). Distinguishing
between sexual and salivary/urinary transmission of ZIKV
becomes difficult due to the correlated nature of behavior
associated with sexual activity (Foy et al., 2011; Musso et al.,
2015a). Verification of ZIKV transmission via sexual interaction
could significantly change the epidemiology of ZIKV as ZIKV
RNA was found to be detectable in semen over a longer period
of time, as compared to blood serum (Foy et al., 2011; Atkinson
et al., 2016).
Blood Transfusion-related Transmission
During the French Polynesia outbreak, ZIKV RNA was detected
in approximately 3% of asymptomatic blood donors (acute
phase of infection) thus, making blood transfusion a novel
potential mode of ZIKV transmission (Musso et al., 2014;
Basarab et al., 2016). ZIKV transmission via blood transfusion
is plausible as ZIKV infections are primarily asymptomatic and
blood transfusion-related transmission of other Flaviviruses have
been reported (Marano et al., 2016; Shah and Kumar, 2016).
The first confirmed case of blood transfusion-related ZIKV
transmission has been recently reported in Brazil (Centers for
Infectious Disease Research and Policy, 2016). To address this
issue, on 19 February 2016, the WHO issued strict guidelines for
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TABLE 2 | Summary of reported association between ZIKV infection and prenatal microcephaly (PM) / GBS.
Country Year No. of
patients
Symptom Sample tested ZIKV detection method References
Slovenia 2015 1 PM Fetal brain tissue qRT-PCR Mlakar et al., 2016
Hawaii 2015 1 PM Not Reported Laboratory confirmation
(method not described)
Hawaii Department of
Health, 2016
Brazil 2015 2 PM Fetal brain tissue RT-PCR & Anti-ZIKV
ELISA
Martines et al., 2016
Brazil 2015 2 PM Amniotic fluid qRT-PCR & ZIKV
sequencing
Calvet et al., 2016
Brazil 2015 1 PM Fetal blood & tissue Genome detection
(method not described)
Pan American Health
Organization, 2016a
Brazil 2015 2 Miscarriage Placental tissue RT-PCR & Anti-ZIKV
ELISA
Martines et al., 2016
Brazil 2015 1 PM Fetal cerebral cortex, medulla oblongata,
cerebrospinal, & amniotic fluid
qPCR Sarno et al., 2016
Brazil 2015 12 PM Fetal cerebrospinal fluid Anti-ZIKV IgM ELISA Lazear and Diamond,
2016
Brazil 2015–2016 12 Fetal Abnormalities Maternal urine and/or blood qRT-PCR Brasil et al., 2016
Brazil 2016 1 PM Fetal brain tissue, membranes, placenta,
& umbilical cord
qRT-PCR Driggers et al., 2016
French Polynesia 2013 1 GBS Serum Anti-ZIKV IgG ELISA &
PRNT
Oehler et al., 2014
French Polynesia 2013–2014 42 GBS Serum Seroneutralization assay
& Anti-ZIKV IgM/IgG
ELISA
Cao-Lormeau et al.,
2016
Martinique 2015 2 GBS Urine RT-PCR World Health
Organization, 2016a
Brazil 2015 7 GBS Not Reported Lab Confirmed World Health
Organization, 2016c
Brazil 2015 4 GBS Serum or cerebrospinal fluid RT-PCR and/or Anti-ZIKV
IgM ELISA
Araujo et al., 2016
Suriname 2015 2 GBS Not reported RT-PCR World Health
Organization, 2016c
Puerto Rico 2015–2016 5 GBS Serum RT-PCR and/or Anti-ZIKV
IgM ELISA
Dirilikov et al., 2016
Venezuela 2016 6 GBS Not Reported RT-PCR World Health
Organization, 2016b
Venezuela 2016 1 GBS Serum & cerebrospinal fluid qRT-PCR Mécharles et al., 2016
PM, Prenatal microcephaly; GBS, Guillain-Barré syndrome; RT-PCR, reverse transcription polymerase chain reaction; qRT-PCR, real time quantitative RT-PCR; Ig, Immunoglobulin;
ELISA, Enzyme-Linked Immunosorbent Assay.
blood transfusion/donation in regions where ZIKV was endemic
(Imperato, 2016). In multiple countries, such as in Europe,
United States, and Canada, donated blood is screened via nucleic
acid testing to detect WNV RNA (O’Brien et al., 2010; Centers
for Disease Control and Prevention, 2013; Pupella et al., 2013).
Adopting the same approach, continuous efforts are in place to
formulate a simple yet precise test to detect ZIKV in donated
blood. An alternative option is to avoid blood donation from
individuals within ZIKV endemic regions or with recent history
of travel to those regions (Lazear and Diamond, 2016). To further
improve transfusion safety, pathogen reduction technologies are
also being utilized to render pathogens inactive (Marano et al.,
2016). Nevertheless, further studies need to be conducted to
detect ZIKV and its transmission in donated blood (Saiz et al.,
2016).
Maternal Transmission
Prenatal Transmission
ZIKV has reportedly been detected in microcephalic neonates
born to mothers with a history of ZIKV infection during
pregnancy (Besnard et al., 2014; Centers for Disease Control and
Prevention, 2016a). It is postulated that ZIKV has the ability
to cross the placenta and subsequently, infect fetal nervous
tissues. The suggested mechanism is supported by the evident
detection of ZIKV RNA and antigens in the amniotic fluid,
placenta, and fetal brain tissue as well as visualization of ZIKV
particles in fetal brain via electronmicroscopy (Calvet et al., 2016;
Lazear and Diamond, 2016; Petersen L. R. et al., 2016). It is a
known fact that the placenta acts as an effective immunological
barrier between the mother and the fetus, protecting the
fetus from microorganisms in the mother’s circulation. The
Frontiers in Microbiology | www.frontiersin.org 6 February 2017 | Volume 8 | Article 110
Sharma and Lal Zika Virus: An Overview
FIGURE 3 | Sylvatic/enzootic and urban transmission cycle of ZIKV. Redrawn based on the information obtained from: Besnard et al. (2014), Musso et al.
(2014), Musso et al. (2015b), Swaminathan et al. (2016), Weaver et al. (2016).
mechanism used by ZIKV to circumvent the placental barrier
is yet to be discovered (Bayer et al., 2016). A recent study on
mouse models discovered that ZIKV infection during pregnancy
resulted in placental damage and fetal death, further supporting
the trans-placental route of transmission (Miner et al., 2016).
The potential of ZIKV to undergo utero transmission has raised
global concerns as regions positive for ZIKV circulation, such
as Brazil, have recently reported a tremendous increase in
the cases of prenatal microcephaly. Accumulating evidences, as
shown in Table 1, suggest the potential ability of ZIKV to be
transmitted to the fetus and the potential role of ZIKV in the
development of prenatal microcephaly (Lazear and Diamond,
2016).
Nursing Mothers
ZIKV RNA and infectious viral particles have been detected
in high loads in the breast milk of infected mothers (Dupont-
Rouzeyrol et al., 2016). This introduces a novel transmission
mechanism in which ZIKV transmission occurs from the mother
to the nursing child. According to a mother-infant pair study,
ZIKV RNA was detected in the breast milk and serum of two
mothers and in the serum of their respective infants (Besnard
et al., 2014). Particularly, serum sample from one of the infants
tested positive via RT-PCR after breastfeeding. However, ZIKV
replication was not detected upon inoculation of the breast
milk on Vero cells hence, making transmission via breast milk
uncertain yet plausible. Other potential confounding mother-to-
child ZIKV transmission routes should be further investigated.
Flavivirus transmission, such as DENV andWNV, via breast milk
have been previously reported (Ognjan et al., 2002; Barthel et al.,
2013).
Transmission by Physical Contact
In September 2016, the first case of ZIKV transmission via
direct physical contact was reported in the United States, further
suggesting a sophisticated and complex ZIKV transmission
mechanism (Swaminathan et al., 2016). The study reported the
transmission of ZIKV from an infected patient (Patient 1: 73-
year-old) to his healthy son (Patient 2: 38-year-old). Patient 1
had returned to the United States from the southwest coast of
Mexico, where ZIKV transmission had been recorded, 8 days
prior to hospitalization in Salt Lake City. Patient 1’s serum assay
for ZIKV via real-time PCR was positive, with an estimation
of a very high viral load. In addition, high-throughput RNA
sequencing of the ZIKV isolated from Patient 1 revealed 99.8%
similarity to the genome sequence of a ZIKV strain circulating
in mosquitoes in Chiapas, Mexico, in 2016. Patient 1 died 4
days after hospitalization. Subsequently, 5 days after Patient 1’s
death, Patient 2 developed ZIKV symptoms. On day seven post-
symptom onset, Patient 2’s urinalysis via PCR assay and serum
IgM antibody test were positive for ZIKV, although blood serum
analysis for ZIKV via PCR was negative. Patient 2 had visited
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Patient 1 during hospitalization and reported to have wiped
Patient 1’s watering eyes without gloves and assisted a nurse in
repositioning Patient 1. None of the health care workers who had
contact with the patients reported having symptomatic illness.
Since the Aedes mosquito species known to transmit ZIKV are
absent in the Salt Lake City area and Patient 2 had not recently
traveled to a ZIKV endemic region and had not had sex with
a partner with recent travel history to such areas, it is most
likely that Patient 2 acquired the ZIKV infection from Patient
1, whose sweat or tears may have contained infectious ZIKV
(Swaminathan et al., 2016).
MODES OF DETECTION
The recent ZIKV outbreak in the Americas and its continuous
spread, along with increased likelihood of causal association
with prenatal microcephaly and GBS has prompted a search
for a low-cost and rapid ZIKV detection method (Pardee
et al., 2016; Vorou, 2016). The present ZIKV outbreaks have
been reported to be of the Asian lineage, hence, current
research focuses on developing Asian strain-specific detection
assays (Charrel et al., 2016). As mentioned earlier, scarce
information is available regarding the pathogenesis of ZIKV
hence, understanding of the ZIKV transmission dynamics
could potentially aid in the development of a robust detection
technique. To date, standardized tests for ZIKV detection have
not yet been developed (Fauci and Morens, 2016). In addition,
clinical presentations of ZIKV infection appear to be highly
similar to other arboviral infections, such as DENV and CHIKV
infection, hence, potentially confounding diagnosis (Basarab
et al., 2016; Fauci and Morens, 2016). In 2015, 224 dengue
patients were screened for ZIKV infection, with seven out of
10 individuals testing positive for ZIKV infection (Agencia
Fiocruz de Noticias, 2016). However, it must be noted that
ZIKV diagnosis and confirmation is challenging due to cross-
reactivity and low viremia (Gourinat et al., 2015). During ZIKV
testing, cross-reactivity to other Flaviviruses often occurs due
to close-relatedness and co-circulation of other Flaviviruses in
ZIKV endemic regions (ZIKV infection is secondary) (Basarab
et al., 2016; Charrel et al., 2016). Detection of ZIKV is best
during the acute-phase, however, it is difficult to determine
the period for onset of symptoms as majority of the cases are
asymptomatic (Shah and Kumar, 2016). Figure 4 summarizes
multiple techniques for ZIKV infection diagnosis.
Reverse Transcription Polymerase Chain
Reaction (RT-PCR)-Based Detection
Real-time and conventional RT-PCR are the most common
approaches utilized in diagnostic labs owing to their specificity
and ability to differentiate ZIKV from other flaviviral infections
(Wong et al., 2016). RT-PCR allows for rapid, specific, and
reliable ZIKV RNA detection during the acute-phase, as
compared to other modes of detection (Marano et al., 2016).
The development of ZIKV specific primers for nested RT-PCR
has been reported to increase specificity (Grard et al., 2014).
Specific RT-PCR molecular assays have been developed for the
detection of Asian and African ZIKV strains. Often, the ZIKV
envelope genes (prM/E protein coding regions) are targeted for
amplification due to their unique characteristics which allow
for differentiation from other Flaviviruses (Musso et al., 2015b;
Marano et al., 2016). Two specific sets of primers for the Asian
ZIKV strain have been tested and established (Lanciotti et al.,
2008). To further increase specificity, the use of TaqMan probe
is recommended (Charrel et al., 2016). Commercial kits (for
research purposes) for ZIKV RNA detection via RT-PCR have
recently entered the market (Charrel et al., 2016).
Peripheral blood samples are predominantly used for PCR-
based assays (Wong et al., 2016). However, RT-PCR on blood
and serum samples is associated with reduced sensitivity due to
low viremia in humans (Vorou, 2016). More recently, detection
of higher viral RNA load over a longer duration was reported in
urine and semen samples (Musso et al., 2015a,b). Related studies
have coherently reported detection of higher DENV and WNV
RNA load over a longer duration in urine samples, as compared
to blood serum (Musso et al., 2015b). ZIKV RNA has also been
reported to be detected in the saliva of infected individuals,
often more readily compared to blood samples (Musso et al.,
2015a). The choice and combination of samples chosen for
testing is highly dependent on the stage of infection (see
Table 3). It is recommended to perform RT-PCR on both blood
and saliva/urine samples in order to increase test sensitivity,
particularly during the late stage of infection (Gourinat et al.,
2015; Musso et al., 2015a). In addition, alternative sampling of
urine or saliva reduces invasiveness and hence, is advantageous
for diagnosis in neonates and infants (Charrel et al., 2016).
For prenatal testing, amniotic fluid is predominantly collected
for molecular analysis. A positive RT-PCR for ZIKV RNA is
suggestive of intrauterine infection and plausible reduction in
fetus fitness (Petersen E. E. et al., 2016). Ultimately, products of
ZIKV RNA specific RT-PCR amplification, regardless of sample
source, cam also be sequenced and aligned against established
ZIKV genome sequences for confirmation (Musso et al., 2015b).
Antibody-Based Detection
Immunoglobulin (Ig) G/M Enzyme-Linked
Immunosorbent Assay (ELISA)
IgM/IgG ELISA involves the detection of ZIKV-specific
antibodies in the serum (Huzly et al., 2016). IgM antibodies are
known to develop within a few days post onset of symptoms
and can last up to 3 months. IgG antibodies on the other hand,
develop after IgM and can last from a few months to years.
IgM specific to ZIKV have been developed at the Centers
for Disease Control and Prevention, Atlanta (Hayes, 2009).
However, studies have reported complications during diagnosis
due to sera cross-reactivity of ZIKV IgM to antibodies against
other Flaviviruses, often in patients with a history of flaviviral
infection or vaccination (Charrel et al., 2016). According to
Hayes (2009), cross-reactivity was predominantly noted with
DENV, as compared to other Flaviviruses. IgM against ZIKV
was detected in the serum as early as 3 days post onset of
symptoms. However, in certain cases, IgM was detected after
the 8th day post-symptom onset, thus introducing uncertainties
in diagnosis. Commercial kits (for research purposes) for rapid
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FIGURE 4 | Proposed flowchart for ZIKV infection diagnosis. This figure is self-drawn based on the information provided in the text (Summary of Section: Modes
of Detection).
TABLE 3 | Molecular detection of ZIKV RNA from different human sample types.
Sample type Primary detection technique Duration for detection References
Blood qRT-PCR Within approximately 5–7 days after onset of symptoms Vorou, 2016
Serum qRT-PCR & Antibody-based detection Within approximately 5–6 days after onset of symptoms Pan American Health Organization, 2016a
Semen qRT-PCR ZIKV RNA detected up to 62 days after onset of symptoms Atkinson et al., 2016
Urine qRT-PCR Within approximately 15 days after onset of symptoms Gourinat et al., 2015
Saliva qRT-PCR ZIKV RNA detected up to 20 days after onset of symptoms Musso et al., 2015a
ZIKV IgM/IgG ELISA detection are readily available in the
market (Charrel et al., 2016).
Plaque Reduction Neutralization Test (PRNT)
PRNT is used for virus-specific neutralizing antibody titer
quantification (Rabe et al., 2016). The test is reported to have
improved specificity compared to ELISA hence, it is often used
in addition to ELISA to rule-out false positive antibody response
(Hayes, 2009; Oehler et al., 2014; Charrel et al., 2016). The PRNT
was used in addition to ELISA for diagnosis and confirmation
of ZIKV in 185 patients during the French Polynesia outbreak
(Duffy et al., 2009). To perform the PRNT, firstly, serum sample
from the patient was diluted and mixed with a suspension of
ZIKV. Subsequently, the mixture was poured over a monolayer
of cells, often Vero or LLC-MK2 cell lines (Lednicky et al.,
2016). The cells were subsequently covered with a thin layer of
agar to avoid viral movement. PRNT against other Flaviviruses
are concurrently performed as a control (Rabe et al., 2016). At
least a 4-fold increase in ZIKV-specific neutralizing antibody
titer is recommended for confirmation of ZIKV infection (Pan
American Health Organization, 2016a). However, interpretation
of results could be complicated if high Flavivirus background
is observed in the patient, often due to history of vaccination
against Flaviviruses (Lanciotti et al., 2008; Rabe et al., 2016).
Toehold Switch Sensor and
CRISPR/cas9-Based Detection
A novel, rapid, and low-cost method for ZIKV RNA detection
has recently been suggested by Pardee et al. (2016). The study
introduces a pipeline for ease of ZIKV RNA detection and ZIKV
strain differentiation using a cell-free approach. Firstly, an RNA
sensor, also known as the toehold switch sensor, programmable
to bind and detect essentially any specific RNA sequence was
developed. For ZIKVdetection, the sensors were designed to bind
specifically to ZIKVRNA and become activated at concentrations
as low as 30 nM. Subsequently, the sensors were embedded into
paper and freeze-dried. This increased sensor stability and ease of
distribution to ZIKV endemic regions. The simple design of the
paper-based sensor allows for rapid mass production at a cost as
low as US$1 per sensor (Dockrill, 2016).
For detection using the paper-based sensor, total RNA
must first be isolated from blood, serum, saliva, or urine and
then subjected to ZIKV genome region specific amplification
using the nucleic acid sequence-based amplification (NASBA)
technique in order to boost ZIKV RNA signaling (Pardee et al.,
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2016). Subsequently, the amplified product is to be applied
to the ZIKV RNA-specific sensor. Samples positive for ZIKV
RNA are visually distinguishable upon the change of sensor
color (from yellow to purple). The viral load in the sample
could also be determined via semi-quantitative analysis (as
described in Pardee et al., 2016). Recently, a CRISPR/Cas9
based module has also been coupled to the NASBA system
hence, allowing different ZIKV strains to be distinguished with
single-base resolution (Pardee et al., 2016). Due to the high
specificity of the sensor to the targeted ZIKV genomic region,
cross-reactivity to other closely related Flaviviruses has been
eliminated. Serum, urine, and saliva samples from infected
patients have been tested using the novel innovation. ZIKV
RNA was successfully documented, with higher loads reported
in urine samples as compared to serum and saliva (Pardee et al.,
2016).
CONTROL MEASURES
Vaccine Development
Vaccines have been successfully developed for protection against
multiple Flaviviruses, such as YFV, TBEV, JEV, and DENV
(Lazear and Diamond, 2016; Weaver et al., 2016). To date,
no vaccine against ZIKV has entered the clinical stage,
therefore, suggesting that ZIKV vaccine establishment is yet
multiple years away (Lazear and Diamond, 2016). Recently,
an Indian biotech company claimed that it has two ZIKV
vaccine candidates awaiting pre-clinical trials (Macdonald,
2016). SynCon Pharmaceuticals (USA) has also developed a
DNA-based vaccine against ZIKV, which is expected to enter
clinical trials by the end of this year (Saiz et al., 2016).
Current ZIKV vaccine development strategies have been targeted
toward adaptation of existing Flavivirus vaccine platforms
(e.g., inactivated or live-attenuated virus, Flavivirus chimera,
glycoprotein subunit technology). The growing threat of an
explosive global spread of ZIKV has drawn an alarming interest
among the scientific community to develop a suitable murine
model for vaccine development (Shah and Kumar, 2016). Since
low genetic variation is observed in different ZIKV strains,
it is likely that a single vaccine may be effective against all
circulating ZIKV strains. However, the effect of pre-existing
immunity against other Flaviviruses on the immunity against
ZIKV must be further investigated (Lazear and Diamond,
2016). In addition, it must be noted that Flavivirus vaccine
development is limited by the nature of outbreaks, being
sporadic and unpredictable. Therefore, rapid vaccine production
to counter the quick spread of ZIKVmay pose difficulties. Besides
that, preemptive vaccination in anticipation of an outbreak
may appear to be prohibitively expensive (Fauci and Morens,
2016).
Antiviral Therapeutics
Since ZIKV vaccine clinical trials are yet underway, more
efforts are being put toward developing antiviral therapeutics
against ZIKV for immediate control (Lazear and Diamond,
2016). Hitherto, there is no established antiviral treatment
available for flaviviral infections (Weaver et al., 2016). Current
ZIKV infection treatment is symptomatic, often through the
use of analgesics and antipyretics (Petersen E. E. et al.,
2016). Human neural progenitor cells derived from induced
pluripotent stem cells have been developed for use as an in
vitro platform for therapeutic compound screening (Tang et al.,
2016). Often, drugs with inhibitory activity against a specific
step in the viral life cycle are targeted. Over the past decade,
significant research has been conducted toward the development
of drugs against DENV. A few drugs that have shown in
vitro inhibition of DENV replication include mefenamic acid,
tetracyclines, amodiaquine, and chloroquine (Wong et al., 2016).
Due to the similarity between ZIKV and DENV, much of the
knowledge-base for DENV drug discovery can potentially be
applied for the development of anti-ZIKV therapeutics (Weaver
et al., 2016). To date, no ZIKV drug screening studies have
been published. Nevertheless, the most challenging obstacle to
overcome in the field of drug development would be the search of
therapeutics for infected pregnant women (Lazear and Diamond,
2016).
Preventative Strategies
Collective responsibility and engagement for integrated
vector management, particularly through the removal of
stagnant water and use of insecticides (diethyltoluamide/ethyl
butylacetylaminopropionate)/larvicides, is greatly emphasized
due to the lack of vaccines and antiviral therapeutics against
ZIKV (Lazear and Diamond, 2016; Pan American Health
Organization, 2016a). Although, A. aegypti and A. albopictus
are primarily responsible for the current ZIKV outbreak,
vector control strategies and vector-pathogen interaction of all
possible mosquito species are advised to be considered owing to
ZIKV’s ability to evolve (Ayres, 2016). It is also recommended
to wear long-sleeved shirts and long pants, even potentially
insecticide-impregnated clothing, in order to minimize vector
contact (Basarab et al., 2016; Weaver et al., 2016). In addition,
men who have a recent travel history to ZIKV endemic
regions are advised to refrain from having unprotected sexual
intercourse with their pregnant partner (Oster et al., 2016). For
asymptomatic travelers returning from ZIKV endemic regions,
barrier contraception for 28 days is recommended (Wong et al.,
2016).
The unexpected potential link between ZIKV infection and
microcephaly has resulted in increased prenatal surveillance in
ZIKV endemic regions (Lazear andDiamond, 2016). Currently, it
is recommended that public health authorities in ZIKV endemic
regions provide access to contraceptives, prenatal care, and
safe abortion services. Efforts toward educating the population,
particularly in ZIKV endemic regions and travelers, regarding the
potential routes of ZIKV transmission and preventative measures
should be greatly emphasized (Lazear and Diamond, 2016).
Increased vigilance toward imported cases of ZIKV infection
and increased surveillance of individuals returning from ZIKV
endemic regions would most certainly reduce autochthonous
ZIKV transmission and global spread (Marano et al., 2016).
In addition to the current existing surveillance systems, more
emphasis should also be put into appropriate ZIKV diagnosis
and monitoring of the potentially associated teratogenic and
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neurological complications (Pan American Health Organization,
2016a). Standard healthcare precautions should also be taken
to eliminate mosquitoes from healthcare facilities in order
to prevent autochthonous ZIKV transmission (Wong et al.,
2016).
Entomological Surveillance
Entomological surveillance allows for early detection of a
potential virus outbreak, vector distribution and density, and
evaluation of vector control strategies (Basarab et al., 2016). Faye
et al. (2014) have designed a specific, rapid, and sensitive one-
step qRT-PCR assay (primers targeting the ZIKV NS5 gene)
for the fast detection of mosquito-originated ZIKV isolates
from Africa and Asia. Several new technologies have shown
to be promising for vector control in ZIKV endemic regions
or upon detecting ZIKV positive mosquitoes in a new region
(Yakob and Walker, 2016). The most simplified and time and
cost-efficient strategy for reducing the mosquito population is
through the introduction of lethal mosquito traps. According to
a study by Barrera et al. (2014), implementation of lethal traps
in two urban areas in Puerto Rice resulted in approximately
50–70% reduction of A. aegypti mosquitoes. A more technical
approach would be through the introduction of genetically
modified male mosquitoes carrying a dominant lethal gene
expressed at the larval stage which causes death in offspring
upon mating with wild female mosquitoes (Wise de Valdez et al.,
2011). Although, this approach has the potential to significantly
reduce the mosquito population, scaling up may be technically
and financially challenging (Weaver et al., 2016). Another
potential strategy, which has shown positive potential for DENV
control, is through the use of the endosymbiotic relationship
between Aedes mosquitoes and the Wolbachia bacteria. The
endosymbiotic relationship interferes with virus replication in
the mosquitoes (inhibitory effect). However, the potential of
the virus to evolve and overcome the inhibitory effect of the
endosymbiotic relationship must be taken in to consideration
(Ritchie et al., 2015).
CONCLUSIONS
The recent ZIKV outbreaks in the Americas have raised alarming
concerns regarding the possible association of ZIKV infection
with unexpected clinical manifestations, such as prenatal
microcephaly and GBS. The risks and severity of ZIKV infection
have been difficult to evaluate due to the poor understanding of
ZIKV transmission dynamics and the absence of standardized
ZIKV detection technique. To this end, evidence from published
reports suggesting the potential association of ZIKV infection
with prenatal microcephaly and GBS have been summarized
in this review. In addition, this review discussed the current
advances in ZIKV transmission and detection and emphasized
the importance of understanding transmission dynamics for
the subsequent development of a rapid cost-effective and time-
efficient ZIKV detection assay and control strategy. Lastly,
strong emphasis on the implementation of stringent surveillance
systems (for humans and mosquitoes) as a preventive strategy is
advised, particularly in tropical regions where the potential for
ZIKV outbreak is more likely.
Further studies could investigate the association between
ZIKV infection and microcephaly/GBS through case-controls
studies in order to rule out potential etiological confounding
factors. Future studies could also explore other potential
ZIKV reservoirs and further investigate the ZIKV pathogenesis
pathways and host cellular response to aid the development of a
robust detection assay, ZIKV vaccine, and antiviral therapeutics.
AUTHOR CONTRIBUTIONS
AS collected data, compiled data and wrote the manuscript, SL
edited and reviewed the manuscript.
ACKNOWLEDGMENTS
This work was supported by internal funds from Monash
University, Malaysia.
REFERENCES
Agencia Fiocruz de Noticias (2016). Fiocruz Pernambuco Answers Questions
About Zika Virus. Available online at: http://www.agencia.fiocruz.br/fiocruz-
pernambuco-esclarece-d%C3%BAvidas-sobrev%C3%ADrus-zika
Althouse, B. M., Vasilakis, N., Sall, A. A., Diallo, M., Weaver, S. C., and Hanley, K.
A. (2016). Potential for Zika virus to establish a sylvatic transmission cycle in
the Americas. BioRxiv. 10:e0005055. doi: 10.1371/journal.pntd.0005055
Araujo, L. M., Ferrerira, M. L. B., and Nascimento, O. J. M. (2016). Guillain-
Barré syndrome associated with the Zika virus outbreak in Brazil. Arquivos de
Neuro-Psiquiatria 274, 253–255. doi: 10.1590/0004-282X20160035
Atkinson, B., Hearn, P., Afrough, B., Lumley, S., Carter, D., Aarons, E. J.,
et al. (2016). Detection of Zika virus in semen. Emerg. Infect. Dis. 22, 940.
doi: 10.3201/eid2205.160107
Ayres, C. F. (2016). Identification of Zika virus vectors and implications for
control. Lancet Infect. Dis. 16, 278–279. doi: 10.1016/S1473-3099(16)00073-6
Baronti, C., Piorkowski, G., Charrel, R. N., Boubis, L., Leparc-Goffart, I., and
Lamballerie, X. (2014). Complete coding sequence of Zika virus from a
French Polynesia outbreak in 2013. Genome Announc. 2, e00500–e00514.
doi: 10.1128/genomeA.00500-14
Barrera, R., Amador, M., Acevedo, V., Caban, B., Felix, G., and Mackay, A.
J. (2014). Use of the CDC autocidal gravid ovitrap to control and prevent
outbreaks of Aedes aegypti (Diptera: Culicidae). J. Med. Entomol. 51, 145–154.
doi: 10.1603/ME13096
Barthel, A., Gourinat, A. C., Cazorla, C., Joubert, C., Dupont-Rouzeyrol,
M., and Descloux, E. (2013). Breast milk as a possible route of vertical
transmission of Dengue virus? Clin. Infect. Dis. 57, 415–417. doi: 10.1093/cid/c
it227
Barzon, L., Pacenti, M., Berto, A., Sinigaglia, A., Franchin, E., Lavezzo, E., et al.
(2016). Isolation of infectious Zika virus from saliva and prolonged viral RNA
shedding in a traveller returning from the Dominican Republic to Italy, January
2016. Euro Surveill. 21:30159. doi: 10.2807/1560-7917.ES.2016.21.10.30159
Basarab, M., Bowman, C., Aarons, E. J., and Cropley, I. (2016). Zika virus. BMJ
352:i1049. doi: 10.1136/bmj.i1049
Bayer, A., Lennemann, N. J., Ouyang, Y., Bramley, J. C., Morosky, S., Marques, E.
T., et al. (2016). Type III interferons produced by human placental trophoblasts
confer protection against Zika virus infection. Cell Host Microbe 19, 705–712.
doi: 10.1016/j.chom.2016.03.008
Berthet, N., Nakouné, E., Kamgang, B., Selekon, B., Descoprs-Declère, S., Gessain,
A., et al. (2014). Molecular characterization of three Zika flaviviruses obtained
Frontiers in Microbiology | www.frontiersin.org 11 February 2017 | Volume 8 | Article 110
Sharma and Lal Zika Virus: An Overview
from sylvatic mosquitoes in the Central African Republic. Vector Borne
Zoonotic Dis. 14, 862–865. doi: 10.1089/vbz.2014.1607
Besnard, M., Lastère, S., Teissier, A., Cao-Lormeau, V. M., and Musso,
D. (2014). Evidence of perinatal transmission of Zika virus, French
Polynesia, December 2013 and February 2014. Euro Surveill. 19:20751.
doi: 10.2807/1560-7917.ES2014.19.13.20751
Brasil, P., Pereira, J. P., Gabaglia, C. R., Damasceno, L., Wakimoto, M.,
Nogueira, R. M. R., et al. (2016). Zika virus infection in pregnant women
in Rio de Janeiro- preliminary report. N. Engl. J. Med. 71, 331–333.
doi: 10.1097/01.ogx.0000483239.08585.8d
Buathong, R., Hermann, L., Thaisomboonsul, B., Rutvisuttinunt, W.,
Klungthong, C., Chinnawirotpisan, P., et al. (2015). Detection of Zika
virus infection in Thailand, 2012-2014. Am. J. Trop. Med. Hyg. 93, 380–383.
doi: 10.4269/ajtmh.15-0022
Buckley, A., and Gould, E. A. (1988). Detection of virus-specific antigen in the
nuclei or nucleoli of cells infected with Zika or Langat virus. J. Gen. Virol. 69,
1913–1929. doi: 10.1099/0022-1317-69-8-1913
Calvet, G., Aguiar, R. S., Melo, A. S., Sampaio, S. A., de Filippis, I., Fabri, A.,
et al. (2016). Detection and sequencing of Zika virus from amniotic fluid of
fetuses withmicrocephaly in Brazil: a case study. Lancet Infect. Dis. 16, 653–660.
doi: 10.1016/S1473-3099(16)00095-5
Cao-Lormeau, V. M., Blake, A., Mons, S., Lastère, S., Vanhomwegen, J., Dub, T.,
et al. (2016). Guillain-Barré Syndrome outbreak associated with Zika virus
infection in French Polynesia: a case-control study. Lancet 387, 1531–1539.
doi: 10.1016/S0140-6736(16)00562-6
Centers for Disease Control and Prevention (2013). Fatal West Nile virus infection
after probable transfusion-associated transmission–Colorado, 2012. MMWR
Morb. Mortal. Wkly. Rep. 62, 622–624.
Centers for Disease Control and Prevention (2016a). Zika Virus: Transmission &
Risks. Available online at: http://www.cdc.gov/zika/transmission/
Centers for Disease Control and Prevention (2016b). Zika virus
disease in the United States, 2015-2016. Available online at:
http://www.cdc.gov/zika/geo/united-states.html
Centers for Disease Control and Prevention Newsroom (2016).
First Female-to-Male Sexual Transmission of Zika Virus
Infection Reported in New York City. Available online at:
http://www.cdc.gov/media/releases/2016/s0715-zika-female-to-male.html
Centers for Infectious Disease Research and Policy (2016). Brazil Confirms
Blood-Transfusion Zika; PAHO Calls For Global Support. Available online
at: http://www.cidrap.umn.edu/news-perspective/2016/02/brazil-confirms-
blood-transfusion-zika-paho-calls-global-support
Charrel, R. N., Leparc-Goffart, I., Pas, S., Lamballerie, X., Koopmans, M., and
Reusken, C. (2016). State of knowledge on Zika virus for an adequate laboratory
response. Bull. World Health Organ. doi: 10.2471/BLT.16.171207. [Epub ahead
of print].
Cugola, F. R., Fernandes, I. R., Russo, F. B., Freitas, B. C., Dias, J. L., Guimarães,
K. P., et al. (2016). The Brazilian Zika virus strain causes bith defects in
experimental models. Nature 534, 267–271. doi: 10.1038/nature18296
Davidson, A., Slavinski, S., Komoto, K., Rakeman, J., and Weiss, D.
(2016). Suspected female-to-male sexual transmission of Zika virus –
New York City, 2016. MMWR Morb. Mortal. Wkly. Rep. 65, 716–717.
doi: 10.15585/mmwr.mm6528e2
Diamond, M. S., Shrestha, B., Mehlhop, E., Sitati, E., and Engle, M. (2004). Innate
and adaptive immune responses determine protection against disseminated
infection by west nile encephalitis virus. Viral Immunol. 16, 259–278.
doi: 10.1089/088282403322396082
Dick, G. W. (1952). Zika virus: pathogenicity and physical properties. Trans. R.
Soc. Trop. Med. Hyg. 46, 521–534. doi: 10.1016/0035-9203(52)90043-6
Dick, G. W., Kitchen, S. F., and Haddow, A. J. (1952). Zika virus. I. Isolations
and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509–520.
doi: 10.1016/0035-9203(52)90042-4
Dirilikov, E., Ryff, K. R., Torress-Aponte, J., Thomas, D. L., Perez-Padilla, J.,
Munoz-Jordan, J., et al. (2016). Update: ongoing Zika virus transmission-
Puerto Rico, November 1, 2015-April 14, 2016. MMWR Morb. Mortal. Wkly.
Rep. 65, 451–455. doi: 10.15585/mmwr.mm6517e2
Dockrill, P. (2016). This New Low-Cost Test Can Diagnose Zika in Just 3 Hours.
Available online at: http://www.sciencealert.com/this-new-low-cost-test-can-
diagnose-zika-in-just-3-hours
Driggers, R. W., Ho, C. Y., Kuivanen, S., Jääskeläinen, A. J., Smura, T.,
Rosenberg, A., et al. (2016). Zika virus infection with prolonged maternal
viremia and fetal brain abnormalities. N. Engl. J. Med. 374, 2142–2151.
doi: 10.1056/NEJMoa1601824
Duffy, M. R., Chen, T. H., Hancock,W. T., Powers, A. M., Kool, J. L., Holzbauer, S.,
et al. (2009). Zika virus outbreak on Yap Island Federated States of Micronesia.
N. Engl. J. Med. 360, 2536–2543. doi: 10.1056/NEJMoa0805715
Dupont-Rouzeyrol, M., Biron, A., O’Connor, O., Huguon, E., and Descloux,
E. (2016). Infectious Zika viral particles in breastmilk. Lancet 387, 1051.
doi: 10.1016/s0140-6736(16)00624-3
Fajardo, Á., Cristina, J., andMoreno, P. (2016). Emergence and spreading potential
of Zika virus. Front. Microbiol. 7:1667. doi: 10.3389/fmicb.2016.01667
Fauci, A. S., and Morens, D. M. (2016). Zika virus in the Americas- yet another
arbovirus threat. N. Engl. J. Med. 374, 601–604. doi: 10.1056/NEJMp1600297
Faye, O., Faye, O., Diallo, D., Diallo, M., Weidmann, M., and Sall, A. (2014).
Quantitative real-time PCR detection of Zika virus and evaluation with field-
caught mosquitoes. J. Virol. 10:311. doi: 10.1186/1743-422X-10-311
Foy, B. D., Kobylinski, K. C., Foy, J. L., Blitvich, B. J., Travassos da
Rosa, A., Haddow, A. D., et al. (2011). Probable non-vector-borne
transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17, 880–882.
doi: 10.3201/eid1705.101939
Gourinat, A., O’Connor, O., Calvez, E., Goarant, C., and Dupont-Rouzeyrol,
M. (2015). Detection of Zika virus in urine. Emerg. Infect. Dis. 21, 84–86.
doi: 10.3201/eid2101.140894
Grard, G., Caron, M., Mombo, I. M., Mkoghe, D., Mboui Ondo, S., Jiolle, D., et al.
(2014). Zika virus in Gabon (central Africa) – 2007: a new threat from Aedes
albopictus? PLoS Negl. Trop. Dis. 8:e2681. doi: 10.1371/journal.pntd.0002681
Haddow, A. D., Schuh, A. J., Yasuda, C. Y., Kasper, M. R., Heang, V.,
Huy, R., et al. (2012). Genetic characterization of Zika virus strains:
geographic expansion of the Asian lineage. PLoS Negl. Trop. Dis. 6:e1477.
doi: 10.1371/journal.pntd.0001477
Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N.,
et al. (2015). Biology of Zika virus infection in human skin cells. J. Virol. 89,
8880–8896. doi: 10.1128/JVI.00354-15
Hawaii Department of Health (2016). DOH News Release: Hawaii Department of
Health Receives Confirmation of Zika Infection in Baby Born with Microcephaly.
Available online at: http://governor.hawaii.gov/newsroom/doh-news-release-
hawaii-department-of-health-receives-confirmation-of-zika-infection-in-
baby-born-with-microcephaly/
Huzly, D., Hanselmann, I., Schmidt-Chanasit, J., and Panning, M. (2016).
High specificity of a novel Zika virus ELISA in European patients
after exposure to different Flaviviruses. Euro Surveill. 21:30203.
doi: 10.2807/1560-7917.ES.2016.21.16.30203
Hayes, E. B. (2009). Zika virus outside Africa. Emerg. Infect. Dis. 15, 1347–1350.
doi: 10.3201/eid1509.090442
Higgs, S. (2016). Zika virus: emergence and emergency. Vector Borne Zoonotic Dis.
16, 75–76. doi: 10.1089/vbz.2016.29001.hig
Hills, S. L., Russell, K., Hennessey, M., Williams, C., Oster, A. M., Fischer, M.,
et al. (2016). Transmission of Zika virus through sexual contact with travelers to
areas of ongoing transmission-continental United States, 2016.MMWR Morb.
Mortal. Wkly. Rep. 65, 215–216. doi: 10.15585/mmwr.mm6508e2
Holmes, E. C. (2003). Patterns of intra-and interhost nonsynonymous variation
reveal strong purifying selection in dengue virus. J. Virol. 77, 11296–11298.
doi: 10.1128/JVI.77.20.11296-11298.2003
Imperato, P. J. (2016). The convergence of a virus, mosquitoes, and human
travel in globalizing the Zika epidemic. J. Commun. Health 41, 674–669.
doi: 10.1007/s10900-016-0177-7
Johnson, B. K., Chanas, A. C., Shockley, P., Squires, E. J., Gardner, P., andWallace,
C. (1977). Arbovirus isolations from, and serological studies on, wild and
domestic vertebrates from Kano Plain, Kenya. Trans. R. Soc. Trop. Med. Hyg.
71, 512–517. doi: 10.1016/0035-9203(77)90146-8
Kostyuchenko, V. A., Lim, E. X., Zhang, S., Fibriansah, G., Ng, T., Ooi, J. S.,
et al. (2016). Structure of the thermally stable Zika virus. Nature 533, 425–428.
doi: 10.1038/nature17994
Lanciotti, R. S., Kosoy, O. L., Laven, J. L., Velez, J. O., Lambert, A. J., Johnson, A.
J., et al. (2008). Genetic and serologic properties of Zika virus associated with
an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis. 14, 1232–1239.
doi: 10.3201/eid1408.080287
Frontiers in Microbiology | www.frontiersin.org 12 February 2017 | Volume 8 | Article 110
Sharma and Lal Zika Virus: An Overview
Lanciotti, R. S., Lambert, A. J., Holodniy, M., Saavedra, S., and Signor Ldel, C.
(2016). Phylogeny of Zika virus in western hemisphere, 2015. Emerg. Infect.
Dis. 22, 933–935. doi: 10.3201/eid2205.160065
Lazear, H. M., and Diamond, M. S. (2016). Zika virus: new clinical syndromes
and its emergence in the western hemisphere. J. Virol. 90, 4864–4875.
doi: 10.1128/JVI.00252-16
Lednicky, J., Beau De Rochars, V. M., El Badry, M., Loeb, J., Telisma, T.,
Chavannes, S., et al. (2016). Zika virus in Haiti in 2014: molecular and clinical
data. PLoS Negl. Trop. Dis. 10:e0004687. doi: 10.1371/journal.pntd.0004687
Macdonald, F. (2016). An Indian Company Says They Have Two Zika Vaccine
Candidates Ready for Pre-clinical Trials. Available online at: http://www.
sciencealert.com/an-indian-company-says-they-have-2-zika-vaccines-ready-
for-pre-clinical-trials
MacNamara, F. N. (1954). Zika virus: a report on three cases of human infection
during an epidemic of juandice in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 48,
139–145. doi: 10.1016/0035-9203(54)90006-1
Mansuy, J. M., Dutertre, M., Mengelle, C., Fourcade, C., Marchou, B.,
Delobel, P., et al. (2016). Zika virus: high infectious viral load in
semen, a new sexually transmitted pathogen? Lancet Infect. Dis. 16, 405.
doi: 10.1016/s1473-3099(16)00138-9
Marano, G., Pupella, S., Vaglio, S., Liumbruno, G. M., and Grazzini, G. (2016).
Zika virus and the never-ending story of emerging pathogens and transfusion
medicine. Blood Transfus. 14, 95–100. doi: 10.2450/2015.0066-15
Marchette, N. J., Garcia, R., and Rudnick, A. (1969). Isolation of Zika virus from
Aedes aegyptimosquitoes in Malaysia. Am. J. Trop. Med. Hyg. 18, 411–415.
Martines, R. B., Bhatnagar, J., Keating, M. K., Silva-Flannery, L., Muehlenbachs,
A., Gary, J., et al. (2016). Evidence of Zika virus infection in brain
and placental tissues from two congenitally infected newborns and two
fetal losses- Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep. 65, 159–160.
doi: 10.15585/mmwr.mm6506e1
Mécharles, S., Herrmann, C., Poullain, P., Tran, T. H., Deschamps, N., Mathon,
G., et al. (2016). Acute myelitis due to Zika virus infection. Lancet 387, 1481.
doi: 10.1016/s0140-6736(16)00644-9
Miner, J. J., Cao, B., Govero, J., Smith, A. M., Fernandez, E., Cabrera, O. H., et al.
(2016). Zika virus infection during pregnancy in mice causes placental damage
and fetal demise. Cell 165, 1081–1091. doi: 10.1016/j.cell.2016.05.008
Mlakar, J., Korva, M., Tul, N., Popovic´, M., Poljšak-Prijatelj, M., Mraz, J., et al.
(2016). Zika virus associated with microcephaly. N. Engl. J. Med. 374, 951–958.
doi: 10.1056/NEJMoa1600651
Musso, D., Nhan, T., Robin, E., Roche, C., Bierlaire, D., Zisou, K., et al.
(2014). Potential for Zika virus transmission through blood transfusion
demonstrated during an outbreak in French Polynesia. Euro Surveill. 19:20761.
doi: 10.2807/1560-7917.ES2014.19.14.20761
Musso, D., Roche, C., Nhan, T. X., Robin, E., Teissier, A., and Cao-Lormeau,
V. M. (2015a). Detection of Zika virus in saliva. J. Clin. Virol. 68, 53–55.
doi: 10.1016/j.jcv.2015.04.021
Musso, D., Roche, C., Robin, E., Nhan, T., Teissier, A., and Cao-Lormeau, V.
M. (2015b). Potential sexual tranmission of Zika virus. Emerg. Infect. Dis. 21,
359–361. doi: 10.3201/eid2102.141363
Nicastri, E., Castilletti, C., Liuzzi, G., Iannetta, M., Capobianchi, M. R., Ippolito,
G. (2016). Persistent detection of Zika virus RNA in semen for six months after
symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro
Surveill. 21:30314. doi: 10.2807/1560-7917.ES.2016.21.32.30314
O’Brien, S. F., Scalia, V., Zuber, E., Hawes, G., Alport, E. C., Goldman, M.,
et al. (2010). West Nile virus in 2006 and 2007: the Canadian Blood Services’
experience. Transfusion 50, 1118–1125. doi: 10.1111/j.1537-2995.2009.02550.x
Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastère, S., Valour, F.,
et al. (2014). Zika virus infection complicated by Guillain-Barré syndrome
– case report, French Polynesia, December 2013. Euro Surveill. 19:20720.
doi: 10.2807/1560-7917.ES2014.19.9.20720
Ognjan, A., Boulton, M. L., Somsel, P., Stobierski, M. G., Stoltman, G., Downes,
K., et al. (2002). Possible West Nile virus transmission to an infant through
breast-feeding-Michigan.MMWRMorb. Mortal. Wkly. Rep. 51, 877–878.
Oster, A. M., Brooks, J. T., Stryker, J. E., Kachur, R. E., Mead, P., Pesik, N. T.,
et al. (2016). Interim guidelines for prevention of sexual transmission of Zika
virus- United States, 2016. MMWR Morb. Mortal. Wkly. Rep. 65, 120–121.
doi: 10.15585/mmwr.mm6505e1
Pan American Health Organization (2016a). Epidemiological Alert: Neurological
Syndrome, Congenital Malformations, and Zika Virus Infection. Available
online at: http://www.paho.org/hq/index.php?option=com_docman&task=
doc_download&Itemid=&gid=32405
Pan American Health Organization (2016b). Zika - Actualización Epidemiológica
Regional de la OPS (Américas) - 7 de julio de 2016. Available at: http://
www.paho.org/hq/index.php?optionDcomcontent&viewDarticle&idD11599:
regional-zika-epidemiological-update-americas&ItemidD41691&langDes
Pan American Health Organization (2016c). Zika virus (ZIKV) – Incidence and
Trends. Available online at: http://www.paho.org/hq/index.php?option=com_
content&view=article&id=11599&Itemid=41691
Pardee, K., Green, A. A., Takahashi, M. K., Braff, D., Lambert, G., Lee, J. W.,
et al. (2016). Rapid, low-cost detection of Zika virus using programmable
biomolecular components. Cell 165, 1255–1266. doi: 10.1016/j.cell.2016.04.059
Petersen, E. E., Staples, J. E., Meaney-Delman, D., Fischer, M., Ellington, S. R.,
Callaghan, W. M., et al. (2016). Interin guidelines for pregnant women during
a Zika virus outbreak- United States, 2016. MMWR Morb. Mortal. Wkly. Rep.
65, 30–33. doi: 10.15585/mmwr.mm6502e1
Petersen, L. R., Jamieson, D. J., Powers, A. M., and Honein, M. A. (2016). Zika
virus. N. Engl. J. Med. 374, 1552–1563. doi: 10.1056/NEJMra1602113
Priyamvada, L., Quicke, K. M., Hudson, W. H., Onlamoon, N., Sewatanon, J.,
Edupuganti, S., et al. (2016). Human antibody responses after dengue virus
infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. U.S.A.
113, 7852–7857. doi: 10.1073/pnas.1607931113
Pupella, S., Cristiano, K., Catalano, L., and Grazzini, G. (2013). West Nile virus
in the transfusion setting with a special focus on Italian preventive measures
adopted in 2008-2012 and their impact on blood safety. Blood Transfus. 11,
563–574. doi: 10.2450/2013.0077-13
Rabe, I. B., Staples, J. E., Villanueva, J., Hummel, K. B., Johnson, J. A.,
Rose, L., et al. (2016). Interim guidance for itnerpretation of Zika virus
antibody test results. MMWR Morb. Mortal. Wkly. Rep. 65, 543–546.
doi: 10.15585/mmwr.mm6521e1
Rasmussen, S. A., Jamieson, D. J., Honein, M. A., and Petersen, L. R. (2016). Zika
virus and birth defects- reviewing the evidence for causality. N. Engl. J. Med.
374, 1981–1987. doi: 10.1056/NEJMsr1604338
Ritchie, S. A., Townsend, M., Paton, C. J., Callahan, A. G., and Hoffmann,
A. A. (2015). Application of wMelPop Wolbachia strain to crash
local populations of Aedes aegypti. PLoS Negl. Trop. Dis. 9:e0003930.
doi: 10.1371/journal.pntd.0003930
Roby, J. A., Setoh, Y. X., Hall, R. A., and Khromykh, A. A. (2015). Post-translational
regulation and modifications of flavivirus structural proteins. J. Gen. Virol. 96,
1551–1569. doi: 10.1099/vir.0.000097
Saiz, J., Vázquez-Calvo, A., Blázquez, A. B., Merino-Ramos, T., Escribano-Romero,
E., and Martin-Acebes, M. A. (2016). Zika virus: the latest newcomer. Front.
Microbiol. 7:496. doi: 10.3389/fmicb.2016.00496
Santora, M. (2016). Twist in Zika Outbreak: New York Case Shows Women Can
Spread It to Men. Available online at: http://www.nytimes.com/2016/07/16/
nyregion/zika-virus-female-to-male-sexual-transmission.html?_r=0
Sarno, M., Sacramento, G. A., Khouri, R., de Rosário, M. S., Costa, F., Archanjo,
G., et al. (2016). Zika virus infection and stillbirths: a case of hydrops
fetalis, hydranencephaly and fetal demise. PLoS Negl. Trop. Dis. 10:e0004517.
doi: 10.1371/journal.pntd.0004517
Shah, A., and Kumar, A. (2016). Zika virus infection and development of
a murine model. Neurotoxcol. Res. 30, 131–134. doi: 10.1007/s12640-016-9
635-3
Shirato, K., Miyoshi, H., Goto, A., Ako, Y., Ueki, T., Kariwa, H., et al. (2004).
Viral envelope protein glycosylation is a molecular determinant of the
neuroinvasiveness of the New York strain of West Nile virus. J. Gen. Virol. 85,
3637–3645. doi: 10.1099/vir.0.80247-0
Slavov, S. N., Otaguiri, K. K., Kashima, S., and Covas, D. T. (2016). Overview of
Zika virus (ZIKV) infection in regards to the Brazilian epidemic. Braz. J. Med.
Biol. Res. 49:e5420. doi: 10.1590/1414-431X20165420
Swaminathan, S., Schlaberg, R., Lewis, J., Hanson, K. E., and Couturier, M. R.
(2016). Fatal Zika virus infection with secondary nonsexual transmission. N.
Engl. J. Med. 375, 1907–1909. doi: 10.1056/nejmc1610613
Tang, H., Hammack, C., Ogden, S. C., Wen, Z., Qian, X., Li, Y., et al.
(2016). Zika virus infects human cortical neural progenitors and attenuates
Frontiers in Microbiology | www.frontiersin.org 13 February 2017 | Volume 8 | Article 110
Sharma and Lal Zika Virus: An Overview
their growth. Cell Stem Cell 18, 587–590. doi: 10.1016/j.stem.2016.0
2.016
Tappe, D., Rissland, J., Gabriel, M., Emmerich, P., Günther, S., Held, G.,
et al. (2014). First case of laboratory-confirmed Zika virus infection
imported into Europe, November 2013. Euro Surveill. 19:20685.
doi: 10.2807/1560-7917.ES2014.19.4.20685
Thomas, S. M., Obermayr, U., Fischer, D., Kreyling, J., and Beierkuhnlein, C.
(2012). Low-temperature threshold for egg survival of a post-diapause and non-
diapause European aedine strain,Aedes albopictus (Diptera: Culicidae). Parasit.
Vectors 5:100. doi: 10.1186/1756-3305-5-100
Ventura, C. V., Maia, M., Bravo-Filho, V., Góis, A. L., and Belfort, R. Jr. (2016).
Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet
387, 228. doi: 10.1016/S0140-6736(16)00006-4
Venturi, G., Zammarchi, L., Fortuna, C., Remoli, M. E., Benedetti, E.,
Fiorentini, C., et al. (2016). An autochthonous case of Zika due to
possible sexual transmission, Florence, Italy, 2014. Euro Surveill. 21:30148.
doi: 10.2807/1560-7917.ES.2016.21.8.30148
Vorou, R. (2016). Zika virus, vectors, reservoirs, amplifying hosts, and their
potential to spread worldwide: what we know and what we should investigate
urgently. Int. J. Infect. Dis. 48, 85–90. doi: 10.1016/j.ijid.2016.05.014
Wang, L., Valderramos, S. G., Wu, A., Ouyang, S., Li, C., Brasil, P., et al. (2016).
From mosquitos to humans: genetic evolution of Zika virus. Cell Host Microbe
19, 561–565. doi: 10.1016/j.chom.2016.04.006
Weaver, S. C., Costa, F., Garcia-Blanco, M. A., Ko, A. I., Ribeiro, G. S., Saade, G.,
et al. (2016). Zika virus: history, emergence, biology, and prospects for control.
Antiviral Res. 130, 69–80. doi: 10.1016/j.antiviral.2016.03.010
Wise de Valdez, M. R., Nimmo, D., Betz, J., Gong, H. F., James, A. A.,
Alphey, L., et al. (2011). Genetic elimination of dengue vector mosquitoes.
Proc. Natl. Acad. Sci. U.S.A. 108, 4772–4775. doi: 10.1073/pnas.10192
95108
Wong, S. S., Poon, R. W., and Wong, S. C. (2016). Zika virus infection-
the next wave after dengue? J. Formos. Med. Assoc. 115, 226–242.
doi: 10.1016/j.jfma.2016.02.002
World Health Organization (2016a). Guillain-Barré Syndrome – France –
Martinique. Available online at: http://www.who.int/csr/don/8-february-2016-
gbs-france-martinique/en/
World Health Organization (2016b). Zika Virus- Epidemiological Update.Available
online at: http://www.paho.org/hq/index.php?option=com_docman&task=
doc_view&Itemid=270&gid=33659&lang=en
World Health Organization (2016c). Zika Virus Microcephaly and Guillain-
Barré Syndrome. Available online at: http://apps.who.int/iris/bitstream/10665/
204491/1/zikasitrep_26Feb2016_eng.pdf?ua=1
Yakob, L., and Walker, T. (2016). Zika virus outbreak in the Americas: the
need for novel mosquito control methods. Lancet Glob. Health 4, e148–e149.
doi: 10.1016/S2214-109X(16)00048-6
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The reviewer CMGDF and handling Editor declared their shared affiliation
and the handling Editor states that the process nevertheless met the standards of a
fair and objective review.
Copyright © 2017 Sharma and Lal. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 14 February 2017 | Volume 8 | Article 110
